サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1635909

医薬品分析試験アウトソーシング市場：タイプ別、サービス別、エンドユーザー別、地域別、2025-2033年

Pharmaceutical Analytical Testing Outsourcing Market by Type (Active Pharmaceutical Ingredients, Additives, Finished Products), Service, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 134 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品分析試験アウトソーシング市場：タイプ別、サービス別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 134 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品分析試験アウトソーシング市場の世界市場規模は2024年に90億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに159億米ドルに達し、2025～2033年の成長率（CAGR）は6.49％になると予測しています。この市場を牽引しているのは、リポソーム、ナノ粒子、マイクロスフェアなどの新しいドラッグデリバリーシステムへの注目の高まり、がん、糖尿病、心血管疾患などの慢性疾患の有病率の増加、医薬品開発への注目の高まりなどです。

医薬品分析試験アウトソーシングは、製薬業界において、業務の一部を第三者に委託することで社内生産コストを最小限に抑えるために利用される試験活動です。医薬品分析試験アウトソーシングサービスは、研究開発業務受託機関の延長として、社内の分析開発・試験のかなりの部分を代替し始めています。医薬品や治療法の開発プロセスの一環として、医薬品試験は製品の初期段階から商品化まで重要な役割を果たしています。化学物質の構造を決定し、混合物質を精製し、医薬品有効成分（API）を合成し、特性を明らかにすることが必要です。製剤開発と初期段階の製造は通常、化合物の活動を加速させるためにこの取り組みに関与します。

医薬品分析試験アウトソーシング市場動向：

市場は、製薬会社、医薬品開発業務受託機関、バイオテクノロジー企業におけるアウトソーシングの導入拡大が主な要因となっています。この背景には、医薬品開発のエンドツーエンドプロセスに関する分析情報に対する規制当局の要求が高まっていることがあります。さらに、製品ライフサイクルの短縮に焦点を当てた継続的な技術の進歩により、新製品の開発が急速に進んでおり、これが市場に拍車をかけています。製品の安全性と品質に対するニーズの高まり、in vivoおよびin vitro試験に関する規制の変化、オーダーメイド医療の重視の高まりも、市場にプラスの影響を与えています。配合剤、バイオシミラー、その他の革新的医薬品の開発は、特定のタイプの検査や特殊製品の製造の導入につながり、市場をさらに活性化しています。その他、製薬業界における数々のイノベーション、アウトソーシングによる価格面でのメリット、持続可能な医薬品開発のために実施される広範な研究開発（R&D）、各国政府による好意的な取り組み、臨床試験登録件数の増加などが市場に貢献しています。

本レポートで扱う主な質問

  • 世界の医薬品分析試験アウトソーシング市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が世界の医薬品分析試験アウトソーシング市場に与えた影響は？
  • 主要地域市場とは？
  • タイプ別の市場内訳は？
  • サービス別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の医薬品分析試験アウトソーシング市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の医薬品分析試験アウトソーシング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 医薬品有効成分（API）
    • 市場動向
    • 市場予測
  • 添加物
    • 市場動向
    • 市場予測
  • 完成品
    • 市場動向
    • 市場予測

第7章 市場内訳：サービス別

  • 生体分析試験
    • 市場動向
    • 主要企業
      • 臨床
      • 非臨床
    • 市場予測
  • 手法開発と検証
    • 市場動向
    • 主要企業
      • 抽出可能・浸出可能
      • 不純物手法
      • 技術コンサルティング
      • その他
    • 市場予測
  • 安定性試験
    • 市場動向
    • 主要企業
      • 薬物成分
      • 安定性指示法の検証
      • 加速安定性試験
      • 光安定性試験
      • その他
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 製薬企業
    • 市場動向
    • 市場予測
  • バイオ医薬品企業
    • 市場動向
    • 市場予測
  • CRO
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Ajinomoto Bio-Pharma Services（Ajinomoto Co. Inc.）
    • Alcami Corporation Inc.
    • Boston Analytical Inc.
    • Catalent Inc.
    • Charles River Laboratories International Inc.
    • Eurofins Scientific SE
    • Intertek Group plc
    • Laboratory Corporation of America Holdings
    • Pace Analytical Services LLC
    • SGS S.A.
    • Thermo Fisher Scientific Inc.
    • West Pharmaceutical Services Inc.
    • WuXi AppTec Inc.
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Service (in %), 2024
  • Figure 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Pharmaceutical Analytical Testing Outsourcing (Active Pharmaceutical Ingredients (API)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Pharmaceutical Analytical Testing Outsourcing (Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Pharmaceutical Analytical Testing Outsourcing (Finished Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Pharmaceutical Analytical Testing Outsourcing (Bioanalytical Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Pharmaceutical Analytical Testing Outsourcing (Method Development and Validation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Pharmaceutical Analytical Testing Outsourcing (Stability Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Pharmaceutical Analytical Testing Outsourcing (Other Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Pharmaceutical Analytical Testing Outsourcing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Pharmaceutical Analytical Testing Outsourcing (Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Pharmaceutical Analytical Testing Outsourcing (Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Pharmaceutical Analytical Testing Outsourcing Industry: SWOT Analysis
  • Figure 78: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Value Chain Analysis
  • Figure 79: Global: Pharmaceutical Analytical Testing Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Service (in Million USD), 2025-2033
  • Table 4: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Pharmaceutical Analytical Testing Outsourcing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Pharmaceutical Analytical Testing Outsourcing Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Analytical Testing Outsourcing Market: Key Players
目次
Product Code: SR112025A6620

The global pharmaceutical analytical testing outsourcing market size reached USD 9.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.49% during 2025-2033. The market is driven by the growing focus on new drug delivery systems, such as liposomes, nanoparticles, and microspheres, increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disease, and rising emphasis on drug development.

Pharmaceutical analytical testing outsourcing is a testing activity used in the pharmaceutical industry to minimize in-house production costs by outsourcing parts of the work to a third party. As an extension of contract research organizations, pharmaceutical analytical testing outsourcing services have begun replacing a significant portion of in-house analytical development and testing. As part of the development process for drugs and therapies, pharmaceutical testing plays a vital role from the beginning through the commercialization of the product. It entails determining the structures of chemicals, purifying a mixture of substances, and synthesizing and characterizing active medicinal ingredients (APIs). Formulation development and early-phase manufacturing are usually involved in this initiative to speed up compound activities.

Pharmaceutical Analytical Testing Outsourcing Market Trends:

The market is majorly driven by the increasing adoption of outsourcing practices in pharmaceutical companies, contract research organizations, and biotech companies. This can be attributed to the escalating demand for analytical information on the end-to-end process of drug development by various regulatory agencies. Additionally, continual technological advancements with an enhanced focus on shortening the product lifecycle have resulted in the rapid development of new products, which is providing an impetus to the market. The rising need for product safety and quality, changing regulations for in vivo and in vitro tests, and an augmented emphasis on customized care is also impacting the market positively. The development of combination products, biosimilar, and other innovative medicines leading to the introduction of specific types of tests and specialty product manufacturing are further fueling the market. Some of the other factors contributing to the market include numerous innovations in the pharmaceutical industry, the pricing benefits of outsourcing, extensive research and development (R&D) conducted to develop sustainable drugs, favorable initiatives by the governments of several countries, and the growing number of clinical trial registrations.

Key Market Segmentation:

Breakup by Type:

Active Pharmaceutical Ingredients (API)

Additives

Finished Products

Breakup by Service:

Bioanalytical Testing

Clinical

Non-Clinical

Method Development and Validation

Extractable and Leachable

Impurity Method

Technical Consulting

Others

Stability Testing

Drug Substance

Stability Indicating Method Validation

Accelerated Stability Testing

Photostability Testing

Others

Others

Breakup by End User:

Pharmaceutical Companies

Biopharmaceutical Companies

Contract Research Organizations

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.), Alcami Corporation Inc., Boston Analytical Inc., Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, SGS S.A., Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc. and WuXi AppTec Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

The global pharmaceutical analytical testing outsourcing market size reached USD 9.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.49% during 2025-2033. The market is driven by the growing focus on new drug delivery systems, such as liposomes, nanoparticles, and microspheres, increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular disease, and rising emphasis on drug development.

Pharmaceutical analytical testing outsourcing is a testing activity used in the pharmaceutical industry to minimize in-house production costs by outsourcing parts of the work to a third party. As an extension of contract research organizations, pharmaceutical analytical testing outsourcing services have begun replacing a significant portion of in-house analytical development and testing. As part of the development process for drugs and therapies, pharmaceutical testing plays a vital role from the beginning through the commercialization of the product. It entails determining the structures of chemicals, purifying a mixture of substances, and synthesizing and characterizing active medicinal ingredients (APIs). Formulation development and early-phase manufacturing are usually involved in this initiative to speed up compound activities.

Pharmaceutical Analytical Testing Outsourcing Market Trends:

The market is majorly driven by the increasing adoption of outsourcing practices in pharmaceutical companies, contract research organizations, and biotech companies. This can be attributed to the escalating demand for analytical information on the end-to-end process of drug development by various regulatory agencies. Additionally, continual technological advancements with an enhanced focus on shortening the product lifecycle have resulted in the rapid development of new products, which is providing an impetus to the market. The rising need for product safety and quality, changing regulations for in vivo and in vitro tests, and an augmented emphasis on customized care is also impacting the market positively. The development of combination products, biosimilar, and other innovative medicines leading to the introduction of specific types of tests and specialty product manufacturing are further fueling the market. Some of the other factors contributing to the market include numerous innovations in the pharmaceutical industry, the pricing benefits of outsourcing, extensive research and development (R&D) conducted to develop sustainable drugs, favorable initiatives by the governments of several countries, and the growing number of clinical trial registrations.

Key Market Segmentation:

Breakup by Type:

Active Pharmaceutical Ingredients (API)

Additives

Finished Products

Breakup by Service:

Bioanalytical Testing

Clinical

Non-Clinical

Method Development and Validation

Extractable and Leachable

Impurity Method

Technical Consulting

Others

Stability Testing

Drug Substance

Stability Indicating Method Validation

Accelerated Stability Testing

Photostability Testing

Others

Others

Breakup by End User:

Pharmaceutical Companies

Biopharmaceutical Companies

Contract Research Organizations

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.), Alcami Corporation Inc., Boston Analytical Inc., Catalent Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Intertek Group plc, Laboratory Corporation of America Holdings, Pace Analytical Services LLC, SGS S.A., Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc. and WuXi AppTec Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global pharmaceutical analytical testing outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical analytical testing outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical analytical testing outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Analytical Testing Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Active Pharmaceutical Ingredients (API)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Additives
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Finished Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Service

  • 7.1 Bioanalytical Testing
    • 7.1.1 Market Trends
    • 7.1.2 Key Players
      • 7.1.2.1 Clinical
      • 7.1.2.2 Non-Clinical
    • 7.1.3 Market Forecast
  • 7.2 Method Development and Validation
    • 7.2.1 Market Trends
    • 7.2.2 Key Players
      • 7.2.2.1 Extractable and Leachable
      • 7.2.2.2 Impurity Method
      • 7.2.2.3 Technical Consulting
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast
  • 7.3 Stability Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Players
      • 7.3.2.1 Drug Substance
      • 7.3.2.2 Stability Indicating Method Validation
      • 7.3.2.3 Accelerated Stability Testing
      • 7.3.2.4 Photostability Testing
      • 7.3.2.5 Others
    • 7.3.3 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biopharmaceutical Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ajinomoto Bio-Pharma Services (Ajinomoto Co. Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alcami Corporation Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Boston Analytical Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Catalent Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Charles River Laboratories International Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Eurofins Scientific SE
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Intertek Group plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Laboratory Corporation of America Holdings
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Pace Analytical Services LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 SGS S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 West Pharmaceutical Services Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 WuXi AppTec Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.